Sei Investments CO Fibrogen Inc Transaction History

Sei Investments CO

$74.7 Billion
Q3 2024

A detailed history of Sei Investments CO transactions in Fibrogen Inc stock. As of the latest transaction made, Sei Investments CO holds 224,654 shares of FGEN stock, worth $78,628. This represents 0.0% of its overall portfolio holdings.

Number of Shares

224,654

Previous 149,342 50.43%

Holding current value

$78,628

Previous $132,000 32.58%

% of portfolio

0.0%

Previous 0.0%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$0.33 - $1.26 $24,852 - $94,893	75,312 Added 50.43%	224,654 $89,000
Q2 2024 Aug 13, 2024	BUY	$0.89 - $2.36 $36,883 - $97,803	41,442 Added 38.41%	149,342 $132,000
Q3 2023 Nov 14, 2023	SELL	$0.79 - $2.83 $46,557 - $166,780	-58,933 Reduced 35.32%	107,900 $92,000
Q2 2023 Aug 11, 2023	BUY	$2.49 - $20.59 $20,831 - $172,255	8,366 Added 5.28%	166,833 $450,000
Q1 2023 May 12, 2023	BUY	$15.95 - $25.18 $208,195 - $328,674	13,053 Added 8.98%	158,467 $2.96 Million
Q4 2022 Feb 10, 2023	BUY	$13.27 - $17.73 $231,442 - $309,228	17,441 Added 13.63%	145,414 $2.33 Million
Q2 2022 Aug 15, 2022	SELL	$7.94 - $12.96 $1,468 - $2,397	-185 Reduced 0.14%	127,973 $1.35 Million
Q1 2022 May 13, 2022	BUY	$12.02 - $16.79 $65,893 - $92,042	5,482 Added 4.47%	128,158 $1.54 Million
Q3 2021 Nov 12, 2021	SELL	$10.18 - $26.64 $322,288 - $843,395	-31,659 Reduced 20.51%	122,676 $1.25 Million
Q2 2021 Aug 06, 2021	SELL	$18.57 - $35.68 $1.01 Million - $1.95 Million	-54,623 Reduced 26.14%	154,335 $4.09 Million
Q1 2021 May 12, 2021	SELL	$31.0 - $55.72 $816,044 - $1.47 Million	-26,324 Reduced 11.19%	208,958 $7.25 Million
Q4 2020 Feb 08, 2021	BUY	$37.09 - $48.97 $1.62 Million - $2.14 Million	43,731 Added 22.83%	235,282 $8.73 Million
Q3 2020 Nov 06, 2020	SELL	$40.47 - $45.5 $605,795 - $681,089	-14,969 Reduced 7.25%	191,551 $7.88 Million
Q2 2020 Aug 17, 2020	BUY	$32.57 - $42.83 $5.58 Million - $7.34 Million	171,371 Added 487.56%	206,520 $8.37 Million
Q2 2020 Aug 11, 2020	SELL	$32.57 - $42.83 $650,227 - $855,058	-19,964 Reduced 36.22%	35,149 $1.51 Million
Q1 2020 May 14, 2020	BUY	$23.3 - $45.96 $465,161 - $917,545	19,964 Added 56.8%	55,113 $1.92 Million
Q4 2019 Feb 06, 2020	BUY	$34.58 - $48.06 $170,583 - $237,079	4,933 Added 16.33%	35,149 $1.51 Million
Q3 2019 Nov 12, 2019	SELL	$36.98 - $48.45 $70,816 - $92,781	-1,915 Reduced 5.96%	30,216 $1.12 Million
Q2 2019 Aug 14, 2019	BUY	$35.13 - $55.53 $255,430 - $403,758	7,271 Added 29.25%	32,131 $1.45 Million
Q1 2019 May 15, 2019	SELL	$42.83 - $59.91 $246,957 - $345,441	-5,766 Reduced 18.83%	24,860 $1.35 Million
Q3 2018 Nov 08, 2018	BUY	$56.3 - $67.25 $160,961 - $192,267	2,859 Added 10.3%	30,626 $1.86 Million
Q2 2018 Aug 03, 2018	SELL	$44.9 - $64.95 $51,679 - $74,757	-1,151 Reduced 3.98%	27,767 $1.74 Million
Q1 2018 May 11, 2018	SELL	$45.35 - $61.65 $48,252 - $65,595	-1,064 Reduced 3.55%	28,918 $1.34 Million
Q4 2017 Feb 08, 2018	SELL	$41.95 - $60.1 $307,241 - $440,172	-7,324 Reduced 19.63%	29,982 $1.42 Million
Q3 2017 Nov 06, 2017	BUY	$33.4 - $53.9 $1.25 Million - $2.01 Million	37,306	37,306 $2.01 Million

Others Institutions Holding FGEN

# of Institutions

Shares Held

47.1M

Call Options Held

387K

Put Options Held

672K

View Full List

About FIBROGEN INC

Ticker FGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,741,200
Market Cap $32.8M
Description
FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic k...

More about FGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sei Investments CO, based on Form 13F filings with the SEC.

News

Stay updated on Sei Investments CO with notifications on news.

Account

Sei Investments CO Fibrogen Inc Transaction History